key: cord-1023079-qvh5yrik authors: Tomasi, Ivan; Scott, Luca; Cullen, Jack; di Maggio, Francesco; Ebied, Husam; Wheatstone, Sarah title: A rare case of heterotopic pancreatitis and intestinal malrotation in a COVID-19 positive patient. COVID-19, causative or coincidence? date: 2021-04-27 journal: Int J Surg Case Rep DOI: 10.1016/j.ijscr.2021.105917 sha: ae24ec07e4faafbb89faaadceaf4cdf82f77659d doc_id: 1023079 cord_uid: qvh5yrik Introduction and importance Heterotopic pancreas (HP) is defined as the presence of pancreatic tissue without anatomical and vascular continuity with the main body of the pancreas. HP typically remains asymptomatic, however complications such as acute pancreatitis can arise. Gastrointestinal involvement with coronavirus disease 2019 (COVID-19) is not uncommon and there are reported cases of associated pancreatitis. Case presentation A 31-year-old male presented to the Emergency department (ED) with a 3-day history of right iliac fossa pain. The patient was found to have COVID-19 and a planned laparoscopic appendectomy was later converted to a midline laparotomy when a mass close to the duodeno-jejunal (DJ) flexure was identified. Following a hand-sewn anastomosis the patient made a good post-operative recovery. Histology illustrated the presence of heterotopic pancreatic tissue within the small bowel with underlying fat necrosis typical of acute pancreatitis. Follow-up radiology supported the intraoperative finding of intestinal malrotation. Clinical Discussion Rarely the combined presence of intestinal malrotation and HP in patients has been noted. Heterotopic pancreatitis can present in a multitude of ways and it is a difficult diagnosis to make pre-operatively. Emerging literature documents the potential presentation of COVID-19 with acute pancreatitis. The expression of angiotensin-converting enzyme 2 (ACE2) receptors on the pancreas is believed to play a role. CONCLUSION: This is the first documented case of heterotopic pancreatitis with intestinal malrotation in a COVID-19 positive patient. We hypothesise that the COVID-19 infection contributed to the heterotopic pancreatitis. 3 with acute pancreatitis. The expression of angiotensin-converting enzyme 2 (ACE2) receptors on the pancreas is believed to play a role. Conclusion: This is the first documented case of heterotopic pancreatitis with intestinal malrotation in a COVID-19 positive patient. We hypothesise that the COVID-19 infection contributed to the heterotopic pancreatitis. Keywords:COVID-19; Case report; Heterotopic pancreatitis. Heterotopic pancreas (HP) or ectopic pancreas is defined as the presence of pancreatic tissue isolated anatomically from the main body of the pancreas, with independent ducts and vascular supply. This rare congenital condition is well reported in the literature as far back as 1727, with first histological confirmation in 1859. (1) HP is documented in between 0.5-13.7% of autopsy studies and identified in 0.5% of laparotomies. (2, 3) HP typically remains asymptomatic and is often found incidentally. However, complications such as inflammation, bleeding, obstruction and malignant transformation can all arise. (1) Acute heterotopic pancreatitis is rare, normally presenting with abdominal pain and can cause an increase in serum pancreatic enzymes. (4, 5) The novel severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) has resulted in the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 has primarily been discussed as disease affecting the respiratory system, however gastrointestinal involvement and more specifically pancreatic injury can also occur. (6, 7) We present a rare case of heterotopic pancreatitis in a COVID-19 positive patient reported in line with the SCARE criteria. (8) To the best of our knowledge, this is a unique case with no similar reports in the medical literature. A 31-year-old male patient, originally from Angola, presented to the Emergency department (ED) with a 3-day history of right iliac fossa pain associated with bilious vomiting. He had been opening his bowels normally with formed stools. This patient had no significant past medical history and was J o u r n a l P r e -p r o o f not taking any regular medications. He was a non-smoker, drinking around 15 units of alcohol a week. On presentation to the ED he was haemodynamically stable and apyrexial. He reported a pain of 4 on a severity scale of 1 to 10. Physical examination revealed rebound tenderness in the right iliac fossa with no palpable masses, and was otherwise unremarkable. A routine SARS-CoV-2 test (polymerase chain reaction -PCR) performed in the ED showed positivity. Urinalysis and a plain film chest radiograph illustrated no abnormalities. His blood tested read; WBC 11.0 (4.0-11.0x10^9) Neutrophils 7. The appendix appeared macroscopically inflamed and was also resected. Frozen sections were not sent during the operation. In our institution, these are predominately available for elective surgery and in this case we do not believe they would have influenced management as the inflamed bowel required resection either way. While there are several proposed theories for the pathogenesis of Heterotopic pancreas (HP), the most commonly held belief is that pancreatic tissue from the ventral and dorsal buds is deposited at ectopic sites during the embryonic rotation of the foregut. (1, 3) Interestingly, our patient was found to have a second abnormal embryonic variant -an intestinal malrotation. The incidence of midgut malrotation is 0.2% and is a deviation from the normal 270-degree counter-clockwise embryological rotation. (9) HP can coexist with other embryological abnormalities such as oesophageal atresia, Meckel diverticulum and intestinal malrotation. (10) While 70-90% of HP localize in the upper gastrointestinal tract (stomach 25-47%, duodenum 11.7-36.3% and proximal jejunum 15-35%), remote sites such as teratomas, fallopian tubes and the mediastinum have also been reported. (1, 2, 11) HP is predominately found in the submucosal layer and classified into three groups based on the presence in the ectopic tissue of ducts, acini and endocrine islets. (1, 2) HP often remains asymptomatic, however as pancreatic tissue, it can undergo inflammation, bleeding, obstruction and malignant transformation. (1) In our case it resulted in acute ectopic pancreatitis within the upper-gastrointestinal tract, previously reported in several cases. (1, 2, 4, 5, 12, 13) It is difficult in these cases to make an accurate pre-operative diagnosis. Our patient was believed to have an acute appendicitis; Rubesin et al discuss a case of presumed jejunal diverticulitis and Mickuniene et al document another case of small bowel HP characterized by bleeding and episodic abdominal pain. Symptomatic HP can indeed have variable presentations and should be considered a rare differential in cases of abdominal pain associated with diagnostic uncertainty. (2, 4) Surgical management was required in the majority of the reviewed cases. Whilst heterotopic pancreatitis is rare, the presence and potentially contributing role of COVID-19 makes our case unique. The novel SARS-CoV-2 RNA virus is responsible for the infectious disease J o u r n a l P r e -p r o o f 8 COVID-19, which has resulted in a global pandemic. (14) SARS-CoV-2 penetrates host cells through binding to the angiotensin-converting enzyme 2 (ACE2) receptor on their surface. (14) Pancreatic involvement in COVID-19 has been reported, varying from an asymptomatic rise in pancreatic enzymes to acute pancreatitis. (6) Several reports have documented COVID-19 to occur with pancreatitis in the absence of other classical aetiological factors such as alcohol and gallstones. (6, 7) Pancreatic islet cells express ACE2 receptors to which SARS-CoV-2 can bind, potentially resulting in direct cytopathic effect and pancreatic injury. Alternatively, indirect immune mediated damage may occur through cytokine storm and a systemic inflammatory response. (6, 14) Inamdar et al found on retrospective analysis a much higher incidence of idiopathic pancreatitis in patients with COVID-19 than in the normal population, suggesting a role for SARS-CoV-2. (15) Our patient was known to drink 15 units of alcohol a week for several years. While acute alcohol intake is a common precipitant for pancreatitis, considering the aforementioned pathophysiological mechanism and the several reported cases of acute pancreatitis in COVID-19 patients, along with the extensive narrative of viral causes of pancreatitis, it seems reasonable to believe that COVID-19 has contributed to the pathology in our case. (7) Furthermore, the patient had no prior sequelae from his alcohol consumption before contracting COVID-19. Gastric heterotopic pancreas: an unusual case and review of the literature A case of ectopic pancreas in the ileum presenting as obscure gastrointestinal bleeding and abdominal pain Diagnosis of ectopic pancreas by endoscopic ultrasound with fine-needle aspiration Ectopic pancreas complicated by pancreatitis and pseudocyst formation mimicking jejunal diverticulitis Acute inflammation occurring in gastric aberrant pancreas followed up by endoscopic ultrasonography COVID-19 Induced Acute Pancreatitis: A Case Report and Literature Review Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP) The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines Midgut malrotation first presenting as acute bowel obstruction in adulthood: a case report and literature review Association of gastric heterotopic pancreas and esophageal atresia in children Changing pattern of ectopic pancreas: 22 years of experience in a medical center Pancreatitis of ectopic pancreatic tissue: a rare cause of gastric outlet obstruction Heterotopic pancreatitis with obstruction of the major duodenal papill--a rare trigger of obstructive orthotopic pancreatitis Treatment for COVID-19: An overview Risk Factors, and Outcomes of Hospitalized Patients With Coronavirus Disease 2019 Presenting as Acute Pancreatitis